Independent community oncology practices are dedicated to providing the best care at locations close to you. A new study confirms that practices are widely adopting new diagnostic tools and treatments like biomarker testing and CAR T therapy, bringing modern solutions to patients. This follow-up study builds on the one released at the 2026 Community Oncology Conference that confirmed that independent community oncology practices deliver care that consistently outperforms national benchmarks. 

COA Asks Supreme Court to Review Mississippi 340B Mandate

COA filed an amicus brief supporting U.S. Supreme Court’s review of Mississippi’s 340B contract pharmacy mandate. The brief explains that the law protects expanding commercial arrangements, including those involving PBM-affiliated pharmacies, without requiring evidence that patients pay less or gain better access to care. COA supports 340B’s safety-net purposes and reasonable safeguards that improve transparency, accountability, and program integrity. Read COA’s SCOTUS Brief.

Survey Shows Widespread Adoption of Cellular Therapies

A survey of COA practices finds 40 percent of respondents are offering or laying the groundwork for cellular therapy, such as CAR T therapy, at their locations. However, practices are finding operational and financial barriers that stand in the way. Read more.

Alex Greenawalt Joins COA as Director of Patient Advocacy

Alex Greenawalt, DBA, is the new Director of Patient Advocacy at COA. Greenawalt leads the COA Patient Advocacy Network (CPAN) and will work to elevate the voices of patients and caregivers in COA’s policy work. Read more.

Clearwater Cancer Institute Hosts Lawmakers for “Sit in My Chair” Practice Visit 

Alabama-based Clearwater Cancer Institute hosted Congressman Dale Strong and state Representative Cindy Myrex this month for a Sit in My Chair event. The lawmakers took a tour of the facility and experienced a “day in the life” of a patient with cancer. Read more.

Oncology Fellows Visit Practices in New York, New Mexico

The COA Fellows Initiative continued its Mentorship program, bringing two groups of fellows to New York Cancer & Blood Specialists and New Mexico Oncology Hematology Consultants. The oncology fellows shadowed established physicians, attended a virtual tumor board, and learned what it’s like to practice in the independent community setting.

Practice Teams: Help Shape COA’s 2027 Advocacy Priorities

COA wants to hear from professionals working in community oncology practices about the issues that matter most to them. Your feedback will help shape our 2027 legislative agenda and advocacy priorities. This survey is for community oncology practice professionals only. Take the survey.

Help Patients Explore CAR T Cell Therapy

 A guide for patients and caregivers to learn more and find resources about each step of the CAR T cell therapy journey. Read more. From Bristol Myers Squibb.

Head and Neck Cancer Resource Guide

A comprehensive collection of resources for patients and caregivers who are dealing with nasopharyngeal carcinoma. Read more. From Coherus Oncology.

Browse all COA Corporate Member Resources

November 9: Delivering Cellular Therapy in Community Oncology: OHC’s Approach

Bringing cellular therapy into the community setting presents new opportunities for patient access—but what does it take to deliver these treatments from start to finish? Join experts from COA and Oncology Hematology Care (OHC) for a virtual webinar exploring the clinical and operational realities of outpatient cellular therapy. Register for the webinar.

November 15-16: East Coast State Legislative Leadership Program Retreat

COA’s two-day state advocacy program prepares community oncology leaders to make a difference at home. Participants learn how state government works, how policy and regulations are developed, and how to build productive relationships with lawmakers. If you are interested in attending the retreat, contact COA at info@coacancer.org.  

November 19: Delivering Bispecific Therapies in Community Oncology: A Focus on Ramp-Up Dosing

Bispecific therapies are creating new treatment options for patients. Join COA and independent oncology experts on Thursday, November 19 at 4 p.m. ET to learn from clinicians who have successfully created a ramp-up dosing program at their practice. Register for the webinar.